You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Psoriatic arthritis
SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20172200
Jul 20171602
Aug 20172800
Sep 20171800
Oct 20171804
Nov 20175203
Dec 20171201
Jan 20183406
Feb 20181700
Mar 20182601
Apr 20183605
May 20181600
Jun 20183201
Jul 20181200
Aug 20182800
Sep 20181204
Oct 20183401
Nov 20181003
Dec 2018403
Feb 20191004
Mar 2019404
Apr 20191403
May 20191404
Jun 2019402
Jul 2019202
Aug 2019202
Sep 2019201
Oct 2019403
Nov 2019002
Dec 2019400
Jan 2020203
Feb 2020001
Mar 20201004
Apr 2020805
May 2020001
Jun 2020800
Jul 2020802
Aug 2020202
Sep 2020802
Oct 2020400
Nov 2020200
Dec 2020803
Jan 2021401
Feb 2021203
Mar 2021400
Apr 2021201
May 2021002
Jun 2021001
Jul 2021003
Aug 2021003
Sep 2021002
Oct 20210017
Nov 20214016
Dec 2021602
Jan 2022201
Feb 2022200
Mar 2022401
Apr 2022602
May 20221207
Jun 20221203
Jul 2022801
Aug 20221003
Sep 2022605
Oct 2022403
Nov 2022601
Dec 2022801
Jan 2023203
Feb 2023400
Mar 2023800
Apr 2023402
May 2023204
Jul 2023402
Aug 2023201
Oct 2023400
Nov 2023001
Dec 2023800
Jan 2024200
Feb 2024405
Mar 20244014
Total6970195